serine has been researched along with imatinib mesylate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, JD; Ikeda, Y; Kizaki, M; Miyakawa, Y; Sawafuji, K; Weisberg, E | 1 |
| Fibach, E; Goldberg, Z; Haupt, Y; Krichevsky, S; Levav, Y | 1 |
| Parker, LL; Tang, J; Wang, JY | 1 |
| Chow, KT; McWhirter, SM; Schlissel, MS; Timblin, GA | 1 |
| Han, BW; Jang, JY; Kim, HJ | 1 |
| Cao, D; Chen, S; Fei, J; Gu, C; Huang, G; Liu, Y; Ou, R; Yang, J; Yin, Z; Zhang, Y | 1 |
6 other study(ies) available for serine and imatinib mesylate
| Article | Year |
|---|---|
Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
Topics: Aminopeptidases; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Caspases; Cell Division; Cyclin D1; Drug Resistance, Neoplasm; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hydroxamic Acids; Imatinib Mesylate; K562 Cells; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Protease Inhibitors; Pyrimidines; Serine; Signal Transduction | 2003 |
Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage.
Topics: Antineoplastic Agents; Benzamides; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Damage; Down-Regulation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Phosphorylation; Piperazines; Protein Kinases; Protein Serine-Threonine Kinases; Pyrimidines; Serine; Tumor Suppressor Protein p53 | 2004 |
Detection of early Abl kinase activation after ionizing radiation by using a peptide biosensor.
Topics: Benzamides; Biosensing Techniques; Cells, Cultured; DNA Damage; Enzyme Activation; HEK293 Cells; Humans; Imatinib Mesylate; Infrared Rays; Morpholines; Peptides; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-abl; Pyrimidines; Pyrones; Radiation, Ionizing; Serine; Structure-Activity Relationship | 2012 |
MK5 activates Rag transcription via Foxo1 in developing B cells.
Topics: Amino Acid Sequence; Animals; B-Lymphocytes; Benzamides; Cell Line, Transformed; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation; Genes, RAG-1; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Molecular Sequence Data; Piperazines; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Sequence Alignment; Serine; Trans-Activators; Transcription, Genetic | 2013 |
Structural Basis for the Regulation of PPARĪ³ Activity by Imatinib.
Topics: Binding Sites; Crystallography, X-Ray; Drug Repositioning; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Imatinib Mesylate; Models, Molecular; Mutation; Phosphorylation; PPAR gamma; Protein Domains; Protein Structure, Secondary; Serine | 2019 |
The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis.
Topics: Animals; Apoptosis; Carcinogenesis; Cell Proliferation; Colony-Forming Units Assay; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Neoplastic Stem Cells; Nuclear Proteins; Phosphorylation; Point Mutation; Protein Kinase Inhibitors; RNA, Small Interfering; Serine; Xenograft Model Antitumor Assays | 2020 |